12:00 AM
 | 
Apr 18, 2011
 |  BC Week In Review  |  Company News  |  Deals

Salix Pharmaceuticals Ltd., Lupin deal

The partners added exclusive, worldwide rights, excluding India, to all rifaximin products covered by Lupin technology or technology jointly developed by the partners to a 2009 deal granting Salix exclusive, U.S. rights to...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >